書誌情報	ファイル
The changes in cell viability induced by miR-222-3p mimic or inhibitor in Patient T2 and T3. (A) APA cells. (B) surrounding “normal adrenal” cells (Supplemental Figure 4)   Okamoto, Kentaro (2025-03-26)
Relative expression levels of the 7 miRNAs that were significantly differentially expressed in the discovery cohort (Supplemental Figure 2)   Okamoto, Kentaro (2025-03-26)
The changes in CYP11B2 expression induced by miR-222-3p mimic or inhibitor in Patient T2 and T3 (Supplemental Figure 3)   Okamoto, Kentaro (2025-03-26)
Comparison of the relative expression level of CYP11B2 mRNA between APA cells and normal adrenal cells (Supplemental Figure 1)   Okamoto, Kentaro (2025-03-26)
The changes in CDKN1B expression induced by miR-222-3p mimic or inhibitor in Patient T2 and T3 (Supplemental Figure 5)   Okamoto, Kentaro (2025-03-26)
The comparison of miR-222-3p expression levels between BHA patients with tumors and those without tumors (Supplemental Figure 6)   Okamoto, Kentaro (2025-03-26)
The clinical characteristics related to AVS and tumors in patients from the discovery and validation cohorts (Supplemental Table 3)   Okamoto, Kentaro (2025-03-26)
The clinical characteristics of the patients used in the primary culture experiment (Supplemental Table 1)   Okamoto, Kentaro (2025-03-26)
The sequences of primers used for qPCR analysis of mRNA expression (Supplemental Table 2)   Okamoto, Kentaro (2025-03-26)
Supplemental Excel data   Okamoto, Kentaro (2025-03-26)
Supplementary data for “Caspase-mediated cleavage of a scaffold protein, MPRIP, yields a truncated form that is involved in repetitive bleb formation”   酒巻, 和弘 (2024-12-20)
Patent landscapes in digital health: Insights from smartphone technologies   森下, 航; 早乙女, 周子 (2024-12-16)
HPH調査票4種   佐々木, 典子; 今中, 雄一 (2024-11-28)
Supplemental Materials: Cervical MUC5B and MUC5AC are barriers to ascending pathogens during pregnancy   Ueda, Yusuke; Mogami, Haruta; Kawamura, Yosuke; Takakura, Masahito; Inohaya, Asako; Yasuda, Eriko; Matsuzaka, Yu; Chigusa, Yoshitsugu; Ito, Shinji; Mandai, Masaki; Kondoh, Eiji (2022-08-18)
Certolizumab pegol for maintenance of medically induced remission in Crohn's disease   Okabayashi, Shinji (2021-08-05)